Dopaminergic Modulation of Cognitive Preparation for Overt Reading: Evidence from the Study of Genetic Polymorphisms

Cerebral Cortex

Volumn 26, Issue 4, 2016, Pages 1539-1557

  Arnold, Christiane ^a   Gispert, Suzana ^a   Bonig, Halvard ^a   Von Wegner, Frederic ^a   Somasundaram, Sriramya ^a   Kell, Christian A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

COMT Val158Met; DAT1 VNTR 9 10; fMRI; inverted U shaped curved cortical subcortical interactions; speech production

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; ANKK1 PROTEIN, HUMAN; COMT PROTEIN, HUMAN; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; DRD2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SLC6A3 PROTEIN, HUMAN;

ADULT; ANTERIOR CINGULATE; ARTICLE; CINGULATE GYRUS; COGNITION; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENE ACTIVATION; GENE INTERACTION; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INFERIOR FRONTAL GYRUS; MALE; NEUROMODULATION; NORMAL HUMAN; OVERT READING; PREFRONTAL CORTEX; PRIORITY JOURNAL; READING; SIGNAL TRANSDUCTION; SPEECH; SUBCORTEX; VARIABLE NUMBER OF TANDEM REPEAT; AXON GUIDANCE; BRAIN; BRAIN MAPPING; GENETICS; GENOTYPE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AXON GUIDANCE; BRAIN; BRAIN MAPPING; CATECHOL O-METHYLTRANSFERASE; COGNITION; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; READING; RECEPTORS, DOPAMINE D2; SPEECH; YOUNG ADULT;

EID: 84963865317     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu330     Document Type: Article

References (116)

1. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. 2003. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci. 23:2008-2013.
2. Alm PA. 2004. Stuttering and the basal ganglia circuits: A critical review of possible relations. J Comm Disord. 37:325-369.
3. Alyea RA, Laurence SE, Kim SH, Katzenellenbogen BS, Katzenellenbogen JA, Watson CS. 2008. The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neurochem. 106:1525-1533.
4. Amara SG, Kuhar MJ. 1993. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 16:73-93.
5. Arnold C, Gehrig J, Gispert S, Seifried C, Kell CA. 2014. Pathomechanisms and compensatory efforts related to Parkinsonian speech. NeuroImage Clin. 4:82-97.
6. Arnsten AFT. 1998. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci. 2:436-447.
7. Arnsten AFT. 1997. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol. 11:151-162.
8. Becker JB. 2008. Oestrogen effects on dopaminergic function in striatum. Neuronal and cognitive effects of oestrogens: Novartis Foundation Symposium 230. Hoboken, NJ: Wiley Online Library.
9. Becker JB, Cha J-h. 1989. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res. 35:117-125.
10. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L, Caforio G, Petruzzella V, Pizzuti A, Scarabino T. 2006. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci. 26:3918-3922.
11. Bilder RM, Volavka J, Lachman HM, Grace AA. 2004. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 29:1943-1961.
12. Camps M, Cortes R, Gueye B, Probst A, Palacios JM. 1989. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience. 28:275-290.
13. Carr DB, Sesack SR. 2000. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci. 20:3864-3873.
14. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Human Genet. 75:807-821.
15. Chudasama Y, Robbins TW. 2004. Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology. 29:1628-1636.
16. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI. 1995. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci. 15:1714-1723.
17. Colzato LS, Waszak F, Nieuwenhuis S, Posthuma D, Hommel B. 2010. The flexible mind is associated with the catechol-Omethyltransferase (COMT) Val158 Met polymorphism: evidence for a role of dopamine in the control of task-switching. Neuropsychologia. 48:2764-2768.
18. Cools R. 2008. Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist. 14:381-395.
19. Cools R, D'Esposito M. 2011. Inverted-U shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry. 69:e113-e125.
20. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. 2008. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci. 28:1208-1212.
21. Cools R, Robbins TW. 2004. Chemistry of the adaptive mind. Philos Trans A Math Phys Eng Sci. 362:2871-2888.
22. de Frias CM, Marklund P, Eriksson E, Larsson A, Öman L, Annerbrink K, Bäckman L, Nilsson LG, Nyberg L. 2010. Influence of COMT gene polymorphism on fMRI-assessed sustained and transient activity during a working memory task. J Cogn Neurosci. 22:1614-1622.
23. Dosenbach NUF, Visscher KM, Palmer ED, Miezin FM,Wenger KK, Kang HC, Burgund ED, Grimes AL, Schlaggar BL, Petersen SE. 2006. A core system for the implementation of task sets. Neuron. 50:799.
24. Doucette-Stamm LA, Blakely DJ, Tian J, Mockus S, Mao J. 1995. Population genetic study of the human dopamine transporter gene (DAT1). Genet Epidemiol. 12:303-308.
25. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF. 2009. Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA. 106:617-622.
26. Dubois B, Pillon B. 1996. Cognitive deficits in Parkinson's disease. J Neurol. 244:2-8.
27. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K. 2005. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage. 25:1325-1335.
28. Finkel D, Reynolds CA, McArdle JJ, Pedersen NL. 2005. The longitudinal relationship between processing speed and cognitive ability: genetic and environmental influences. Behav Genet. 35:535-549.
29. Floresco SB, Magyar O. 2006. Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology. 188:567-585.
30. Floresco SB, West AR, Ash B, Moore H, Grace AA. 2003. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci. 6:968-973.
31. Frank MJ. 2005. Dynamic dopamine modulation in the basal ganglia: A neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci. 17:51-72.
32. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. 1995. Spatial registration and normalization of images. Hum Brain Mapp. 3:165-189.
33. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ. 1997. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage. 6:218-229.
34. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. 1994. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp. 2:189-210.
35. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. 2001. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 1:152-156.
36. Garcia-Garcia M, Barcelo F, Clemente IC, Escera C. 2010. The role of the dopamine transporter DAT1 genotype on the neural correlates of cognitive flexibility. Eur J Neurosci. 31:754-760.
37. Giros B, Caron MG. 1993. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci. 14:43.
38. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. 1998. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA. 95:9991-9996.
39. Goldman-Rakic PS, Muly EC III,Williams GV. 2000. D1 receptors in prefrontal cells and circuits. Brain Res Rev. 31:295-301.
40. Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience. 41:1-24.
41. Guenther FH. 2006. Cortical interactions underlying the production of speech sounds. J Comm Disord. 39:350-365.
42. Happel MFK, Deliano M, Handschuh J, Ohl FW. 2014. Dopaminemodulated recurrent corticoefferent feedback in primary sensory cortex promotes detection of behaviorally relevant stimuli. J Neurosci. 34:1234-1247.
43. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, LinnoilaM,Weinberger DR. 2000. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 22:133-139.
44. Hickok G, Houde J, Rong F. 2011. Sensorimotor integration in speech processing: computational basis and neural organization. Neuron. 69:407-422.
45. Hickok G, Poeppel D. 2007. The cortical organization of speech processing. Nat Rev Neurosci. 8:393-402.
46. Ho AK, BradshawJL, Iansek R. 2000. Volume perception in Parkinsonian speech. Mov Disord. 15:1125-1131.
47. Hosp JA, Hertler B, Atiemo CO, Luft AR. 2011. Dopaminergic modulation of receptive fields in rat sensorimotor cortex. Neuroimage. 54:154-160.
48. Hosp JA, Pekanovic A, Rioult-Pedotti MS, Luft AR. 2011. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. J Neurosci. 31:2481-2487.
49. Jacobs E, D'Esposito M. 2011. Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J Neurosci. 31:5286-5293.
50. Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M. 2009. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. J Neurosci. 29:3695-3704.
51. Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry. 4:290-296.
52. Kang AM, Palmatier MA, Kidd KK. 1999. Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry. 46:151-160.
53. KaroumF, Chrapusta SJ, Egan MF. 1994. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem. 63:972-979.
54. Karreman M, Moghaddam B. 1996. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J Neurochem. 66:589-598.
55. Kell CA, Morillon B, Kouneiher F, Giraud AL. 2011. Lateralization of speech production starts in sensory cortices-A possible sensory origin of cerebral left dominance for speech. Cereb Cortex. 21:932-937.
56. Kell CA, Neumann K, Von Kriegstein K, Posenenske C, Von Gudenberg AW, Euler H, Giraud AL. 2009. How the brain repairs stuttering. Brain. 132:2747-2760.
57. Kinsbourne M, Hicks RE. 1978. Functional cerebral space: A model for overflow, transfer and interference effects in human performance. Attention Performance 7:345-362.
58. Koechlin E, Ody C, Kouneiher F. 2003. The architecture of cognitive control in the human prefrontal cortex. Science. 302:1181-1185.
59. Kolachana BS, Saunders RC,Weinberger DR. 1995. Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey. Neuroscience. 69:859-868.
60. Kouneiher F, Charron S, Koechlin E. 2009. Motivation and cognitive control in the human prefrontal cortex. Nat Neurosci. 12:939-945.
61. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. 1996. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 6:243.
62. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT. 2000. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 10:120-131.
63. Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A. 2001. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol. 432:119-136.
64. Lindenberger U, Nagel IE, Chicherio C, Li SC, Heekeren HR, Bäckman L. 2008. Age-related decline in brain resources modulates genetic effects on cognitive functioning. Front Neurosci. 2:234-244.
65. Lindvall O, Bjorklund A. 1978. Anatomy of the dopaminergic neuron systems in the rat brain. Adv Biochem Psychopharmacol. 19:1.
66. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. 1995. Kinetics of human soluble and membranebound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 34:4202-4210.
67. Marklund P, Larsson A, Elgh E, Linder J, Riklund KA, Forsgren L, Nyberg L. 2009. Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory. Brain. 132:336-346.
68. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, Kleinman JE, Weinberger DR. 2003. Catechol Omethyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience. 116:127-138.
69. Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen J, Hyde TM, Herman MM, Weinberger DR, Kleinman JE. 2003. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology. 28:1521-1530.
70. Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE,Weinberger DR. 2000. Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage. 12:268-275.
71. McDermott JL, Liu B, Dluzent DE. 1994. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol. 125:306-311.
72. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R, Weinberger DR, Berman KF. 2005. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci. 8:594-596.
73. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 7:818-827.
74. Mill J, Asherson P, Browes C, D'Souza U, Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet. 114:975-979.
75. Mink JW. 1996. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol. 50:381-425.
76. Monchi O, Petrides M, Doyon J, Postuma RB,Worsley K, Dagher A. 2004. Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci. 24:702-710.
77. Monchi O, Petrides M, Mejia-Constain B, Strafella AP. 2007. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain. 130: 233-244.
78. Moore RY, Bloom FE. 1978. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci. 1:129-169.
79. Nagano-Saito A, Leyton M, Monchi O, Goldberg YK, He Y, Dagher A. 2008. Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task. J Neurosci. 28:3697-3706.
80. Nagel IE, Chicherio C, Li SC, Von Oertzen T, Sander T, Villringer A, Heekeren HR, Bäckman L, Lindenberger U. 2008. Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci. 2:1-8.
81. Noble EP. 2000. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics. 1:309-333.
82. Nymberg C, Banaschewski T, Bokde ALW, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A. 2014. DRD2/ANKK1 polymorphism modulates the effect of ventral striatal activation on working memory performance. Neuropsychopharmacology. 39:2357-2365.
83. O'Reilly JX, Jbabdi S, Rushworth MFS, Behrens TEJ. 2013. Brain systems for probabilistic and dynamic prediction: computational specificity and integration. PLoS Biol. 11:e1001662.
84. Oldfield RC. 1971. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia. 9:97-113.
85. Palmatier MA, Kang AM, Kidd KK. 1999. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry. 46:557-567.
86. Pasqualini C, Olivier V, Guibert B, Frain O, Leviel V. 1995. Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem. 65:1651-1657.
87. Pichon S, Kell CA. 2013. Affective and sensorimotor components of emotional prosody generation. J Neurosci. 33:1640-1650.
88. Pohjalainen T, Rinne JO, Naygren K, Lehikoinen P, Anttila K, Syvalahti EK, Hietala J. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry. 3:256.
89. Preibisch C, Raab P, Neumann K, Euler HA, von Gudenberg AW, Gall V, Lanfermann H, Zanella F. 2003. Event-related fMRI for the suppression of speech-associated artifacts in stuttering. Neuroimage. 19:1076-1084.
90. Reuter M, Montag C, Peters K, Kocher A, Kiefer M. 2009. The modulatory influence of the functional COMT Val158Met polymorphism on lexical decisions and semantic priming. Front Hum Neurosci. doi:10.3389/neuro.09.020.2009.
91. Reuter M, Peters K, Schroeter K, Koebke W, Lenardon D, Bloch B, Hennig J. 2005. The influence of the dopaminergic system on cognitive functioning: A molecular genetic approach. Behav Brain Res. 164:93-99.
92. Ritchie T, Noble EP. 2003. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res. 28:73-82.
93. Rorden C, Brett M. 2000. Stereotaxic display of brain lesions. Behav Neurol. 12:191-200.
94. Sakai K, Passingham RE. 2006. Prefrontal set activity predicts rule-specific neural processing during subsequent cognitive performance. J Neurosci. 26:1211-1218.
95. Sano A, Kondoh K, Kakimoto Y, Kondo I. 1993. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet. 91:405-406.
96. SchultzW, Apicella P, Scarnati E, Ljungberg T. 1992. Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci. 12:4595-4610.
97. Seamans JK, Yang CR. 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 74:1-58.
98. Servan-Schreiber D, Printz H, Cohen JD. 1990. A network model of catecholamine effects: gain, signal-to-noise ratio, and behavior. Science. 249:892-895.
99. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. 1998. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci. 18:2697-2708.
100. Simonyan K, Berman BD, Herscovitch P, Hallett M. 2013. Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci. 33:14705-14714.
101. Simonyan K, Herscovitch P, Horwitz B. 2013. Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: A combined PET, fMRI and DTI study. Neuroimage. 70:21-32.
102. Soderqvist S, Matsson H, Peyrard-Janvid M, Kere J, Klingberg T. 2014. Polymorphisms in the dopamine receptor 2 gene region influence improvements during working memory training in children and adolescents. J Cogn Neurosci. 26:54-62.
103. Stelzel C, Basten U, Montag C, Reuter M, Fiebach CJ. 2009. Effects of dopamine-related gene-gene interactions on working memory component processes. Eur J Neurosci. 29: 1056-1063.
104. Stelzel C, Basten U, Montag C, Reuter M, Fiebach CJ. 2010. Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density. J Neurosci. 30:14205-14212.
105. Stuss DT, Alexander MP. 2007. Is there a dysexecutive syndrome? Philos Trans Roy Soci Biol Sci. 362:901-915.
106. Talairach J, Tournoux P. 1988. Co-planar stereotaxic atlas of the human brain. New York: Thieme New York.
107. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 7:479-484.
108. van Schouwenburg M, Aarts E, Cools R. 2010. Dopaminergic modulation of cognitive control: distinct roles for the prefrontal cortex and the basal ganglia. Curr Pharm Des. 16:2026-2032.
109. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR. 1992. Human dopamine transporter gene (DAT1) maps to chromosome 5p15. 3 and displays a VNTR. Genomics. 14:1104-1106.
110. VanNess SH, Owens MJ, Kilts CD. 2005. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet. 6:55.
111. Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA. 2007. Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci. 27: 4832-4838.
112. Williams GV, Castner SA. 2006. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience. 139:263-276.
113. Williams GV, Goldman-Rakic PS. 1995. Modulation of memory fields by dopamine Dl receptors in prefrontal cortex. Nature. 376:572-575.
114. Wu JC, Maguire G, Riley G, Lee A, Keator D, Tang C, Fallon J, Najafi A. 1997. Increased dopamine activity associated with stuttering. Neuroreport. 8:767-770.
115. Xiao L, Becker JB. 1994. Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett. 180:155-158.
116. Yacubian J, Sommer T, Schroeder K, Gläscher J, Kalisch R, Leuenberger B, Braus DF, Büchel C. 2007. Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA. 104:8125-8130.